Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)
Clinical trial NCT00095576 · TERMINATED
Trial details
- NCT number
- NCT00095576
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-09-01
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.